TB Vaccine Enters Human Clinical Trials

Researchers from Seattle-based Infectious Disease Research Institute have developed an experimental tuberculosis (TB) vaccine candidate called ID93. The National Institutes of Health (NIH) has reported the freeze-dried, temperature-stable candidate has begun an initial phase of clinical trials in humans. Image Credit   The NIH’s National Institute of Allergy and Infectious Diseases is collaborating on the...+